Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.
ADVANCED SEARCH
Log in
Top
Inflammopharmacology
Published in: Inflammopharmacology 4/2017

01-08-2017 | Review

Melatonin as an anti-inflammatory agent in radiotherapy

Authors: M. Najafi, A. Shirazi, E. Motevaseli, A. H. Rezaeyan, A. Salajegheh, S. Rezapoor

Published in: Inflammopharmacology | Issue 4/2017

Login to get access

Abstract

Radiotherapy is one of the most relevant treatment options for cancer therapy with or without other treatment modalities including immunotherapy, surgery and chemotherapy. Exposure to heavy doses of ionizing radiation during radiotherapy results in short and long term side effects. It appears that many of these side effects are linked to inflammatory responses during treatment or after prolonged use. Inflammation is mediated by various genes and cytokines related to immune system responses caused by massive cell death following radiotherapy. This phenomenon is more obvious, particularly after exposure to clinical doses of radiotherapy. Inflammation is involved in the amplification of acute responses, genomic instability and also long term pathological changes in normal tissues. Moreover, inflammation attenuates responses of the tumor to radiotherapy through some mechanisms such as angiogenesis. Thus, the management of inflammation is one of the most interesting aims in cancer radiotherapy. Melatonin, known as a natural product in the body, has been of much interest for its anti-inflammatory properties. Some studies have proposed melatonin as a novel anti-inflammation agent. This literature review will concentrate on the anti-inflammatory properties of melatonin that may help the management of different inflammatory signaling pathways in both tumor and normal tissues.
Literature
Adams MJ, Hardenbergh PH, Constine LS, Lipshultz SE (2003) Radiation-associated cardiovascular disease. Crit Rev Oncol Hematol 45(1):55–75PubMedCrossRef
Aghazadeh S et al (2007) Melatonin as a protective agent in spinal cord damage after gamma irradiation. Rep Prac Oncol Radiother 12(2):95–99CrossRef
Andreassen CN, Grau C, Lindegaard JC (2003) Chemical radioprotection: a critical review of amifostine as a cytoprotector in radiotherapy. Semin Radiat Oncol 13:62–72PubMedCrossRef
Antolín ISAAC et al (1996) Neurohormone melatonin prevents cell damage: effect on gene expression for antioxidant enzymes. FASEB J 10(8):882–890PubMed
Apetoh L et al (2007) Toll-like receptor 4-dependent contribution of the immune system to anticancer chemotherapy and radiotherapy. Nat Med 13(9):1050–1059PubMedCrossRef
Balamurugan K (2016) HIF-1 at the crossroads of hypoxia, inflammation, and cancer. Int J Cancer 138(5):1058–1066PubMedCrossRef
Balkwill F, Charles KA, Mantovani A (2005) Smoldering and polarized inflammation in the initiation and promotion of malignant disease. Cancer Cell 7(3):211–217PubMedCrossRef
Bangha E, Elsner P, Kistler GS (1996) Suppression of UV-induced erythema by topical treatment with melatonin (N-acetyl-5-methoxytryptamine). A dose response study. Arch Dermatol Res 288(9):522–526PubMedCrossRef
Becciolini A et al (1997) The effects of irradiation at different times of the day on rat intestinal goblet cells. Cell Prolif 30(3–4):161–170PubMedCrossRef
Ben-David MA et al (2015) Melatonin for Prevention of Breast Radiation Dermatitis: A Phase II, Prospective, Double-Blind Randomized Trial. Isr Med Assoc J IMAJ 18(3–4):188–192
Bentzen SM (2006) Preventing or reducing late side effects of radiation therapy: radiobiology meets molecular pathology. Nat Rev Cancer 6(9):702–713PubMedCrossRef
Bertuglia S, Marchiafava PL, Colantuoni A (1996) Melatonin prevents ischemia reperfusion injury in hamster cheek pouch microcirculation. Cardiovasc Res 31(6):947–952PubMedCrossRef
Bhatia AL, Manda K (2004) Study on pre-treatment of melatonin against radiation-induced oxidative stress in mice. Environ Toxicol Pharmacol 18(1):13–20PubMedCrossRef
Bordt SL et al (2001) N1E-115 mouse neuroblastoma cells express mt1 melatonin receptors and produce neurites in response to melatonin. Biochim Et Biophys Acta (BBA) Mol Cell Res 1499(3):257–264CrossRef
Borek C (2004) Antioxidants and radiation therapy. J Nutr 134(11):3207S–3209SPubMed
Bower JE et al (2011) Inflammation and behavioral symptoms after breast cancer treatment: do fatigue, depression, and sleep disturbance share a common underlying mechanism? J Clin Oncol 29(26):3517–3522PubMedPubMedCentralCrossRef
Carrillo-Vico A et al (2003) Expression of membrane and nuclear melatonin receptor mRNA and protein in the mouse immune system. Cell Mol Life Sci CMLS 60(10):2272–2278PubMedCrossRef
Cayli SR et al (2004) Effect of combined treatment with melatonin and methylprednisolone on neurological recovery after experimental spinal cord injury. Eur Spine J 13(8):724–732PubMedPubMedCentralCrossRef
Cerutti P, Amstad P (1993) Inflammation and oxidative stress in carcinogenesis. Eicosanoids and Other Bioactive Lipids in Cancer, Inflammation and Radiation Injury. Springer, New York, pp 387–390
Chen LD et al (1995) Melatonin’s inhibitory effect on growth of ME-180 human cervical cancer cells is not related to intracellular glutathione concentrations. Cancer Lett 91(2):153–159PubMedCrossRef
Choi YW et al (2004) Effects of Radiation Therapy on the Lung: Radiologic Appearances and Differential Diagnosis 1. Radiographics 24(4):985–997PubMedCrossRef
Chun KS et al (2004) Nitric oxide induces expression of cyclooxygenase-2 in mouse skin through activation of NF-κB. Carcinogenesis 25(3):445–454PubMedCrossRef
Ciriaco M et al (2013) Corticosteroid-related central nervous system side effects. J Pharmacol Pharmacother 4(5):94CrossRef
Colombo J et al (2016) Effects of melatonin on HIF-1alpha and VEGF expression and on the invasive properties of hepatocarcinoma cells. Oncol Lett 12(1):231–237PubMedPubMedCentral
Condeelis J, Pollard JW (2006) Macrophages: obligate partners for tumor cell migration, invasion, and metastasis. Cell 124(2):263–266PubMedCrossRef
Cos S et al (1996) Effects of melatonin on the proliferation and differentiation of human neuroblastoma cells in culture. Neurosci Lett 216(2):113–116PubMedCrossRef
Delia P et al (2002) Prevention of radiation-induced diarrhea with the use of VSL# 3, a new high-potency probiotic preparation. Am J Gastroenterol 97(8):2150PubMedCrossRef
Deng WG et al (2006) Melatonin suppresses macrophage cyclooxygenase-2 and inducible nitric oxide synthase expression by inhibiting p52 acetylation and binding. Blood 108(2):518–524PubMedPubMedCentralCrossRef
Doctrow SR et al (2013) A synthetic superoxide dismutase/catalase mimetic EUK-207 mitigates radiation dermatitis and promotes wound healing in irradiated rat skin. J Invest Dermatol 133(4):1088–1096PubMedCrossRef
Dörr W, Hendry JH (2001) Consequential late effects in normal tissues. Radiother Oncol 61(3):223–231PubMedCrossRef
Dragicevic N et al (2011) Melatonin treatment restores mitochondrial function in Alzheimer’s mice: a mitochondrial protective role of melatonin membrane receptor signaling. J Pineal Res 51(1):75–86PubMedCrossRef
Dunst J et al (2000) Intermittent use of amifostine during postoperative radiochemotherapy and acute toxicity in rectal cancer patients. Strahlenther Onkol 176(9):416–421PubMedCrossRef
El-Missiry MA et al (2007) Ameliorative effect of melatonin against gamma-irradiation-induced oxidative stress and tissue injury. Ecotoxicol Environ Saf 66(2):278–286PubMedCrossRef
Esrefoglu M et al (2006) Ultrastructural clues for the potent therapeutic effect of melatonin on aging skin in pinealectomized rats. Fundam Clin Pharmacol 20(6):605–611PubMedCrossRef
Fischer TW et al (2008) Melatonin as a major skin protectant: from free radical scavenging to DNA damage repair. Exp Dermatol 17(9):713–730PubMedCrossRef
Forrest LM et al (2003) Evaluation of cumulative prognostic scores based on the systemic inflammatory response in patients with inoperable non-small-cell lung cancer. Br J Cancer 89(6):1028–1030PubMedPubMedCentralCrossRef
Foulkes NS, Borjigin J, Snyder SH (1997) Rhythmic transcription: the molecular basis of circadian melatonin synthesis. Trends Neurosci 20(10):487–492PubMedCrossRef
Georgakilas AG (2015) Role of the immune system and inflammation in ionizing radiation effects. Cancer Lett 368(2):154PubMedCrossRef
Gilad E et al (1998) Melatonin inhibits expression of the inducible isoform of nitric oxide synthase in murine macrophages: role of inhibition of NFκB activation. FASEB J 12(9):685–693PubMed
Gitto E et al (2001) Individual and synergistic antioxidative actions of melatonin: studies with vitamin E, vitamin C, glutathione and desferrrioxamine (desferoxamine) in rat liver homogenates. J Pharm Pharmacol 53(10):1393–1401PubMedCrossRef
Guney Y et al (2007) Melatonin prevents inflammation and oxidative stress caused by abdominopelvic and total body irradiation of rat small intestine. Braz J Med Biol Res 40(10):1305–1314PubMedCrossRef
Gupta SC et al (2010) Regulation of survival, proliferation, invasion, angiogenesis, and metastasis of tumor cells through modulation of inflammatory pathways by nutraceuticals. Cancer Metastasis Rev 29(3):405–434PubMedPubMedCentralCrossRef
Haddadi G et al (2013) Radioprotective effect of melatonin on the cervical spinal cord in irradiated rats. Cell J (Yakhteh) 14(4):246
Halin C, Detmar M (2008) Inflammation, angiogenesis, and lymphangiogenesis. Methods Enzymol 445:1–25PubMedCrossRef
Hekim N et al (2015) Radiation triggering immune response and inflammation. Cancer Lett 368(2):156–163PubMedCrossRef
Hicklin DJ, Ellis LM (2005) Role of the vascular endothelial growth factor pathway in tumor growth and angiogenesis. J Clin Oncol 23(5):1011–1027PubMedCrossRef
Hong JH et al (1995) Induction of acute phase gene expression by brain irradiation. Int J Radiat Oncol Biol Phys 33(3):619–626PubMedCrossRef
Hovdenak N, Fajardo LF, Hauer-Jensen M (2000) Acute radiation proctitis: a sequential clinicopathologic study during pelvic radiotherapy. Int J Radiat Oncol Biol Phys 48(4):1111–1117PubMedCrossRef
Hovdenak N et al (2003) Profiles and time course of acute radiation toxicity symptoms during conformal radiotherapy for cancer of the prostate. Acta Oncol 42(7):741–748PubMedCrossRef
Hu ZP et al (2013) Melatonin ameliorates vascular endothelial dysfunction, inflammation, and atherosclerosis by suppressing the TLR4/NF-κB system in high-fat-fed rabbits. J Pineal Res 55(4):388–398PubMed
Huether G (1993) The contribution of extrapineal sites of melatonin synthesis to circulating melatonin levels in higher vertebrates. Experientia 49(8):665–670PubMedCrossRef
Hussein MR et al (2005) Ultrastructural evaluation of the radioprotective effects of melatonin against X-ray-induced skin damage in Albino rats. Int J Exp Pathol 86(1):45–55PubMedPubMedCentralCrossRef
Hussein MR et al (2008) Melatonin and roentgen irradiation-induced acute radiation enteritis in Albino rats: an animal model. Cell Biol Int 32(11):1353–1361PubMedCrossRef
Inoue A et al (2001) Radiation pneumonitis in lung cancer patients: a retrospective study of risk factors and the long-term prognosis. Int J Radiat Oncol Biol Phys 49(3):649–655PubMedCrossRef
Jang SS et al (2013) Melatonin reduces X-ray radiation-induced lung injury in mice by modulating oxidative stress and cytokine expression. Int J Radiat Biol 89(2):97–105PubMedCrossRef
Jardim-Perassi BV et al (2016) Melatonin regulates angiogenic factors under hypoxia in breast cancer cell lines. Anticancer Agents Med Chem 16(3):347–358PubMedCrossRef
Jung JI et al (2004) Thoracic Manifestations of Breast Cancer and Its Therapy 1. Radiographics 24(5):1269–1285PubMedCrossRef
Kaya H et al (1999) The effect of melatonin on lipid peroxidation during radiotherapy in female rats. Strahlenther Onkol 175(6):285–288PubMedCrossRef
Kim BC et al (2001) Melatonin reduces X-ray irradiation-induced oxidative damages in cultured human skin fibroblasts. J Dermatol Sci 26(3):194–200PubMedCrossRef
Koc M et al (2003) Melatonin protects rat liver against irradiation-induced oxidative injury. J Radiat Res 44(3):211–215PubMedCrossRef
Komaki R et al (2004) Effects of amifostine on acute toxicity from concurrent chemotherapy and radiotherapy for inoperable non–small-cell lung cancer: Report of a randomized comparative trial. Int J Radiat Oncol Biol Phys 58(5):1369–1377PubMedCrossRef
Kotler M et al (1998) Melatonin increases gene expression for antioxidant enzymes in rat brain cortex. J Pineal Res 24(2):83–89PubMedCrossRef
Lan F et al (2014) Serum toll-like receptors are potential biomarkers of radiation pneumonia in locally advanced NSCLC. Int J Clin Exp Pathol 7(11):8087–8095PubMedPubMedCentral
Li F, Sethi G (2010) Targeting transcription factor NF-κB to overcome chemoresistance and radioresistance in cancer therapy. Biochim Et Biophys Acta (BBA) Rev Cancer 2:167–180CrossRef
Lin R et al (2015) Chronic inflammation-related DNA damage response: a driving force of gastric cardia carcinogenesis. Oncotarget 6(5):2856PubMedCrossRef
Lissoni P et al (2001) Anti-angiogenic activity of melatonin in advanced cancer patients. Neuro Endocrinol Lett 22(1):45–47PubMed
Lorimore SA et al (2001) Inflammatory-type responses after exposure to ionizing radiation in vivo: a mechanism for radiation-induced bystander effects? Oncogene 20(48):7085–7095PubMedCrossRef
Lugade AA et al (2008) Radiation-induced IFN-γ production within the tumor microenvironment influences antitumor immunity. J Immunol 180(5):3132–3139PubMedCrossRef
Mahal HS, Sharma HS, Mukherjee T (1999) Antioxidant properties of melatonin: a pulse radiolysis study. Free Radic Biol Med 26(5):557–565PubMedCrossRef
Marozik P et al (2007) Bystander effects induced by serum from survivors of the Chernobyl accident. Exp Hematol 35(4):55–63PubMedCrossRef
Matuszak Z, Reszka KJ, Chignell CF (1997) Reaction of melatonin and related indoles with hydroxyl radicals: EPR and spin trapping investigations. Free Radic Biol Med 23(3):367–372PubMedCrossRef
Mayo JC et al (2002) Melatonin regulation of antioxidant enzyme gene expression. Cell Mol Life Sci CMLS 59(10):1706–1713PubMedCrossRef
Mayo JC et al (2005) Anti-inflammatory actions of melatonin and its metabolites, N1-acetyl-N2-formyl-5-methoxykynuramine (AFMK) and N1-acetyl-5-methoxykynuramine (AMK), in macrophages. J Neuroimmunol 165(1–2):139–149PubMedCrossRef
Meacham LR, Sklar CA, Li S, Liu Q, Gimpel N, Yasui Y, Whitton JA, Stovall M, Robison LL, Oeffinger KC (2009) Diabetes mellitus in long-term survivors of childhood cancer. Arch Inter Med 169 (15):1381CrossRef
Mehta V (2005) Radiation pneumonitis and pulmonary fibrosis in non–small-cell lung cancer: Pulmonary function, prediction, and prevention. Int J Radiat Oncol Biol Phys 63(1):5–24PubMedCrossRef
Meira LB et al (2008) DNA damage induced by chronic inflammation contributes to colon carcinogenesis in mice. J Clin Investig 118(7):2516–2525PubMedPubMedCentral
Min D et al (2002) Protection from thymic epithelial cell injury by keratinocyte growth factor: a new approach to improve thymic and peripheral T-cell reconstitution after bone marrow transplantation. Blood 99(12):4592–4600PubMedCrossRef
Mohan N et al (1995) The neurohormone melatonin inhibits cytokine, mitogen and ionizing radiation induced NF-kappa B. Biochem Mol Biol Int 37(6):1063–1070PubMed
Mohseni M et al (2012) Melatonin may play a role in modulation of bax and bcl-2 expression levels to protect rat peripheral blood lymphocytes from gamma irradiation-induced apoptosis. Mutat Res Fundam Mol Mech Mutagen 738–739:19–27CrossRef
Monobe M et al (2005) Protective effects of melatonin on gamma-ray induced intestinal damage. Int J Radiat Biol 81(11):855–860PubMedCrossRef
Movsas B et al (1997) Pulmonary radiation injury. Chest J 111(4):1061–1076CrossRef
Mukherjee D et al (2014) Responses to ionizing radiation mediated by inflammatory mechanisms. J Pathol 232(3):289–299PubMedCrossRef
Najafi M et al (2016) Radiation-induced oxidative stress at out-of-field lung tissues after pelvis irradiation in rats. Cell J (Yakhteh) 18(3):340
Nooshinfar E et al (2016) Melatonin, an inhibitory agent in breast cancer. Breast Cancer 24:1–10
Fardid R, Salajegheh A, Mosleh-Shirazi MA, Sharifzadeh S, Okhovat MA, Najafi M, Rezaeyan A, Abaszadeh A (2017) Melatonin ameliorates the production of COX-2, iNOS, and the formation of 8-OHdG in non-targeted lung tissue after pelvic irradiation. Cell J 19(2):324–331PubMedPubMedCentral
Okatani Y et al (2001) Melatonin stimulates glutathione peroxidase activity in human chorion. J Pineal Res 30(4):199–205PubMedCrossRef
Onal C et al (2011) Protective effects of melatonin and octreotide against radiation-induced intestinal injury. Dig Dis Sci 56(2):359–367PubMedCrossRef
Ong ZY et al (2010) Pro-inflammatory cytokines play a key role in the development of radiotherapy-induced gastrointestinal mucositis. Radiat Oncol 5(1):1CrossRef
Ortiz F et al (2015) Melatonin blunts the mitochondrial/NLRP3 connection and protects against radiation-induced oral mucositis. J Pineal Res 58(1):34–49PubMedCrossRef
Pablos MI et al (1995) Melatonin stimulates the activity of the detoxifying enzyme glutathione peroxidase in several tissues of chicks. J Pineal Res 19(3):111–115PubMedCrossRef
Pablos MI et al (1998) Rhythms of glutathione peroxidase and glutathione reductase in brain of chick and their inhibition by light. Neurochem Int 32(1):69–75PubMedCrossRef
Peddi PF, Shatsky RA, Hurvitz SA (2014) Noninfectious pneumonitis with the use of mTOR inhibitors in breast cancer. Cancer Treat Rev 40(2):320–326PubMedCrossRef
Perez-Sala D, Lamas S (2001) Regulation of cyclooxygenase-2 expression by nitric oxide in cells. Antioxid Redox Signal 3(2):231–248PubMedCrossRef
Philip B et al (2013) HIF expression and the role of hypoxic microenvironments within primary tumours as protective sites driving cancer stem cell renewal and metastatic progression. Carcinogenesis 34(8):1699–1707PubMedCrossRef
Reiter RJ, Tan DX, Burkhardt S (2002) Reactive oxygen and nitrogen species and cellular and organismal decline: amelioration with melatonin. Mech Ageing Dev 123(8):1007–1019PubMedCrossRef
Reits EA et al (2006) Radiation modulates the peptide repertoire, enhances MHC class I expression, and induces successful antitumor immunotherapy. J Exp Med 203(5):1259–1271PubMedPubMedCentralCrossRef
Rezaeyan A et al (2016a) Evaluating radioprotective effect of hesperidin on acute radiation damage in the lung tissue of rats. J Biomed Phys Eng 6(3):165–174PubMedPubMedCentral
Rezaeyan A et al (2016b) Radioprotective effects of hesperidin on oxidative damages and histopathological changes induced by X-irradiation in rats heart tissue. J Med Phys Assoc Med Phys India 41(3):182
Rezvani M (2003) Treatment of radiation-induced normal tissue lesions. Iran J Radiat Res 1(2):63–78
Roach MIII et al (1995) Radiation pneumonitis following combined modality therapy for lung cancer: analysis of prognostic factors. J Clin Oncol 13(10):2606–2612PubMedCrossRef
Robbins MEC, Zhao W (2004) Chronic oxidative stress and radiation-induced late normal tissue injury: a review. Int J Radiat Biol 80(4):251–259PubMedCrossRef
Rodriguez C et al (2004) Regulation of antioxidant enzymes: a significant role for melatonin. J Pineal Res 36(1):1–9PubMedCrossRef
Rosiello RA, Merrill WW (1990) Radiation-induced lung injury. Clin Chest Med 11(1):65–71PubMed
Roth JA, Rabin R, Agnello K (1997) Melatonin suppression of PC12 cell growth and death. Brain Res 768(1–2):63–70PubMedCrossRef
Rubio S et al (2007) Inhibition of proliferation and induction of apoptosis by melatonin in human myeloid HL-60 cells. J Pineal Res 42(2):131–138PubMedCrossRef
Sainz RM et al (2003a) Melatonin and cell death: differential actions on apoptosis in normal and cancer cells. Cell Mol Life Sci 60(7):1407–1426PubMedCrossRef
Sainz RM et al (2003b) Antioxidant activity of melatonin in Chinese hamster ovarian cells: changes in cellular proliferation and differentiation. Biochem Biophys Res Commun 302(3):625–634PubMedCrossRef
Sekine I et al (2006) Retrospective analysis of steroid therapy for radiation-induced lung injury in lung cancer patients. Radiother Oncol 80(1):93–97PubMedCrossRef
Şener G et al (2003) Melatonin ameliorates ionizing radiation-induced oxidative organ damage in rats. Life Sci 74(5):563–572PubMedCrossRef
Serin M et al (2007) The histopathological evaluation of the effectiveness of melatonin as a protectant against acute lung injury induced by radiation therapy in a rat model. Int J Radiat Biol 83(3):187–193PubMedCrossRef
Sewerynek E et al (1995) Oxidative damage in the liver induced by ischemia-reperfusion: protection by melatonin. Hepatogastroenterology 43(10):898–905
Shakhov AN et al (2012) Prevention and mitigation of acute radiation syndrome in mice by synthetic lipopeptide agonists of Toll-like receptor 2 (TLR2). PLoS One 7(3):e33044PubMedPubMedCentralCrossRef
Shiao SL, Coussens LM (2010) The tumor-immune microenvironment and response to radiation therapy. J Mammary Gland Biol Neoplas 15(4):411–421CrossRef
Shirazi A (2011) Radioprotective effect of melatonin in reducing oxidative stress in rat lenses. Radiother Oncol 98:S21CrossRef
Shirazi A, Mahdavi SR, Trott KR (2004) Radiation myelopathy: a radiobiological review. Rep Pract Oncol Radiother 9(4):119–127CrossRef
Shirazi A et al (2005) Short-term changes in prostacyclin secretory profile of irradiated rat cervical spinal cord. Prostaglandins Leukot Essent Fat Acids 72(5):373–378CrossRef
Shirazi A et al (2010) Evaluation of melatonin for modulation of apoptosis-related genes in irradiated cervical spinal cord. Int J Low Radiat 7(6):436–445CrossRef
Shirazi A et al (2013a) Radio-protective effects of melatonin against irradiation-induced oxidative damage in rat peripheral blood. Phys Med 29(1):65–74PubMedCrossRef
Shirazi A et al (2013b) Evaluation of radio-protective effect of melatonin on whole body irradiation induced liver tissue damage. Cell 14(4):294–297
Slominski A, Pruski D (1993) Melatonin inhibits proliferation and melanogenesis in rodent melanoma cells. Exp Cell Res 206(2):189–194PubMedCrossRef
Slominski A et al (2008) Melatonin in the skin: synthesis, metabolism and functions. Trends Endocrinol Metab 19(1):17–24PubMedCrossRef
Somosy Z et al (2002) Morphological aspects of ionizing radiation response of small intestine. Micron 33(2):167–178PubMedCrossRef
Sprung CN et al (2015) Immunological markers that predict radiation toxicity. Cancer Lett 368(2):191–197PubMedCrossRef
Stasica P, Ulanski P, Rosiak JM (1998) Melatonin as a hydroxyl radical scavenger. J Pineal Res 25(1):65–66PubMedCrossRef
Tan DX et al (2003) Mechanistic and comparative studies of melatonin and classic antioxidants in terms of their interactions with the ABTS cation radical. J Pineal Res 34(4):249–259PubMedCrossRef
Tan DX et al (2007) One molecule, many derivatives: A never-ending interaction of melatonin with reactive oxygen and nitrogen species? J Pineal Res 42(1):28–42PubMedCrossRef
Tan DX et al (2013) Mitochondria and chloroplasts as the original sites of melatonin synthesis: a hypothesis related to melatonin’s primary function and evolution in eukaryotes. J Pineal Res 54(2):127–138PubMedCrossRef
Tan DX et al (2015) Melatonin as a potent and inducible endogenous antioxidant: synthesis and metabolism. Molecules 20(10):18886–18906PubMedCrossRef
Tavassoli A, Ghasemi D (2015) Radioprotective effect of melatonin on radiation-induced lung injury and lipid peroxidation in rats. Cell J 17(1):111PubMedPubMedCentral
Tsoutsou PG, Koukourakis MI (2006) Radiation pneumonitis and fibrosis: mechanisms underlying its pathogenesis and implications for future research. Int J Radiat Oncol Biol Phys 66(5):1281–1293PubMedCrossRef
Wang Y et al (2004) Activation of nuclear factor κB in vivo selectively protects the murine small intestine against ionizing radiation-induced damage. Cancer Res 64(17):6240–6246PubMedCrossRef
Yang QH et al (2007) Antiproliferative effects of melatonin on the growth of rat pituitary prolactin-secreting tumor cells in vitro. J Pineal Res 42(2):172–179PubMedCrossRef
Yi C et al (2014) Melatonin enhances the anti-tumor effect of fisetin by inhibiting COX-2/iNOS and NF-κB/p300 signaling pathways. PLoS One 9(7):e99943PubMedPubMedCentralCrossRef
Yilmaz S, Yilmaz E (2006) Effects of melatonin and vitamin E on oxidative–antioxidative status in rats exposed to irradiation. Toxicology 222(1):1–7PubMedCrossRef
Ying SW, Niles LP, Crocker C (1993) Human malignant melanoma cells express high-affinity receptors for melatonin: antiproliferative effects of melatonin and 6-chloromelatonin. Eur J Pharmacol Mol Pharmacol 246(2):89–96CrossRef
Zhang S et al (2013) Melatonin inhibits cell growth and migration, but promotes apoptosis in gastric cancer cell line, SGC7901. Biotech Histochem 88(6):281–289PubMedCrossRef
Zhao W, Robbins MEC (2009) Inflammation and chronic oxidative stress in radiation-induced late normal tissue injury: therapeutic implications. Curr Med Chem 16(2):130–143PubMedCrossRef
Metadata
Title
Melatonin as an anti-inflammatory agent in radiotherapy
Authors
M. Najafi
A. Shirazi
E. Motevaseli
A. H. Rezaeyan
A. Salajegheh
S. Rezapoor
Publication date
01-08-2017
Publisher
Springer International Publishing
Published in
Inflammopharmacology / Issue 4/2017
Print ISSN: 0925-4692
Electronic ISSN: 1568-5608
DOI
https://doi.org/10.1007/s10787-017-0332-5

Other articles of this Issue 4/2017

Inflammopharmacology 4/2017 Go to the issue

Original Article

Effects of antirheumatic drug underutilization on rheumatoid arthritis disease activity

Erratum

Erratum to: Antinociceptive interaction of gabapentin with minocycline in murine diabetic neuropathy

Review

Role of LPS-elicited signaling in triggering gastric mucosal inflammatory responses to H. pylori: modulatory effect of ghrelin

Original Article

Hypermagnesemia disturbances in rats, NO-related: pentadecapeptide BPC 157 abrogates, l-NAME and l-arginine worsen

Review

Nrf2: a potential therapeutic target for diabetic neuropathy

Review

Dynamin-related protein-1 as potential therapeutic target in various diseases